# Optimal Timing of Zoster Vaccine After Zoster Illness

> **NCT02704572** · NA · COMPLETED · sponsor: **Seoul National University Hospital** · enrollment: 60 (actual)

## Conditions studied

- Shingles

## Interventions

- **BIOLOGICAL:** Zostavax

## Key facts

- **NCT ID:** NCT02704572
- **Lead sponsor:** Seoul National University Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-03
- **Primary completion:** 2017-08
- **Final completion:** 2017-08
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2017-10-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02704572

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02704572, "Optimal Timing of Zoster Vaccine After Zoster Illness". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT02704572. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*